News
03-11-2011, 06:40 AM
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today reported fourth-quarter and full-year 2010 financial results, provided an update on recent progress with its programs, and announced 2011 objectives.
More... (http://www.news-medical.net/news/20110311/Synta-fourth-quarter-total-collaboration-revenue-decreases-to-2430-million.aspx)
More... (http://www.news-medical.net/news/20110311/Synta-fourth-quarter-total-collaboration-revenue-decreases-to-2430-million.aspx)